Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitisJulián Panés, Josep M. Piqué, Joaquín Hinojosa et al.|Gastroenterology|2000Cited by 11
Estimation of induction and maintenance costs of Infliximab, Adalimumab and Cer-tolizumab Pegol in managing Crohnʼs DiseaseBrian G. Feagan, Martin C. Brown, Samuel Chin Wei Tan et al.|Inflammatory Bowel Diseases|2008Cited by 0